Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "Mila"

783 News Found

Biocon and Viatris receive EC approval for Biosimilar Bevacizumab
Biotech | April 28, 2021

Biocon and Viatris receive EC approval for Biosimilar Bevacizumab

The drug is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer and ovarian, cervical and renal cancer


Pharma industry bullish on complex generics and biosimilars
News | February 25, 2021

Pharma industry bullish on complex generics and biosimilars

While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side


Unichem Laboratories receives ANDA approval for Apremilast Tablets
News | February 20, 2021

Unichem Laboratories receives ANDA approval for Apremilast Tablets

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .


Biocon Biologics and Viatris receive European Commission approval for Kixelle, Biosimilar Insulin Aspart
Biotech | February 13, 2021

Biocon Biologics and Viatris receive European Commission approval for Kixelle, Biosimilar Insulin Aspart

The centralized marketing authorization granted by the EC is valid in all EU Member


Biocon Biologics to offer its oncology biosimilars in 30+ countries
Biotech | February 05, 2021

Biocon Biologics to offer its oncology biosimilars in 30+ countries

The partnership is a significant step in delivering advanced cancer therapies to patients.


Slow recovery in biosimilars for Biocon: ICICI Securities
News | January 26, 2021

Slow recovery in biosimilars for Biocon: ICICI Securities

Dr Christiane Hamacher, has stepped down as the MD of Biocon Biologics and will be succeeded by Dr Arun Chandavarkar.


Teva study shows Huntington’s disease treatment improves life for patients & caregivers
Clinical Trials | June 24, 2026

Teva study shows Huntington’s disease treatment improves life for patients & caregivers

The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life


European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
Drug Approval | June 24, 2026

European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment

Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data


FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
News | June 23, 2026

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average


HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted